|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | |
| A61K 47/36 | |||
| A61K 31/661 | |||
| A61K 31/573 | |||
| A61K 45/06 | |||
| A61P 29/00 |
| (11) | Number of the document | 3247329 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16705864.3 |
| Date of filing the European patent application | 2016-01-20 | |
| (97) | Date of publication of the European application | 2017-11-29 |
| (45) | Date of publication and mention of the grant of the patent | 2021-05-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/014165 |
| Date | 2016-01-20 |
| (87) | Number | WO 2016/118649 |
| Date | 2016-07-28 |
| (30) | Number | Date | Country code |
| 201562106045 P | 2015-01-21 | US |
| (72) |
SHAH, Mahendra, G., US
|
| (73) |
Semnur Pharmaceuticals, Inc.,
960 San Antonio Road Suite 100, Palo Alto, CA 94303,
US
|
| (54) | INJECTABLE PHARMACEUTICAL COMPOSITION COMPRISING DEXAMETHASONE SODIUM PHOSPHATE |
| INJECTABLE PHARMACEUTICAL COMPOSITION COMPRISING DEXAMETHASONE SODIUM PHOSPHATE |